SRZNW:Wt Exp 08/01/2032/Surrozen Inc - Stock Price Quote and Dividend Data
SRZNW STOCK PRICE LATEST CLOSE
$0.02
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Wt Exp 08/01/2032/Surrozen Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Wt Exp 08/01/2032/Surrozen Inc Stock Price Information
52-Week Low/High Stock Price$0.01 - $0.09
Percent Held by Institutions27.45%
Revenue$11,310,000
Net Income$-91,603,000
Cash Flow$-14,147,000
EPS-9.10%
Market Cap$0
PE Ratio to Industry123%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-13.05%
Total Return Last 3 Years-91.60%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 08, 2025
Wt Exp 08/01/2032/Surrozen Inc Annual Stock Dividends
No Data available for Payment History.
Wt Exp 08/01/2032/Surrozen Inc Dividend Payment History
| No dividends retrieved for SRZNW |
Wt Exp 08/01/2032/Surrozen Inc Other Dividend Details
Surrozen, Inc. is a clinical-stage biotechnology company. Co. is engaged in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a range of organs and tissues. Co. is developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with a current focus on severe liver and eye diseases. Its two lead product candidates include SZN-043 and SZN-413. SZN-043 is the first development candidate using Surrozen's SWEETS technology. It is developing SZN-043 for severe liver diseases, initially focusing on alcohol-associated hepatitis.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 03, 2025SRZNW STOCK PRICE DECREASE: Wt Exp 08/01/2032/Surrozen Inc on 04-03-2025 decreased stock price > 10% from $0.03 to $0.02
Mar. 15, 2025SRZNW STOCK PRICE INCREASE: Wt Exp 08/01/2032/Surrozen Inc on 03-15-2025 increased stock price > 10% from $0.04 to $0.05
Mar. 14, 2025SRZNW STOCK PRICE INCREASE: Wt Exp 08/01/2032/Surrozen Inc on 03-14-2025 increased stock price > 10% from $0.02 to $0.04
Mar. 11, 2025SRZNW STOCK PRICE DECREASE: Wt Exp 08/01/2032/Surrozen Inc on 03-11-2025 decreased stock price > 10% from $0.05 to $0.02
Mar. 08, 2025SRZNW STOCK PRICE INCREASE: Wt Exp 08/01/2032/Surrozen Inc on 03-08-2025 increased stock price > 10% from $0.02 to $0.05
Mar. 05, 2025SRZNW STOCK PRICE DECREASE: Wt Exp 08/01/2032/Surrozen Inc on 03-05-2025 decreased stock price > 10% from $0.03 to $0.02
Feb. 25, 2025SRZNW STOCK PRICE INCREASE: Wt Exp 08/01/2032/Surrozen Inc on 02-25-2025 increased stock price > 10% from $0.03 to $0.04
Feb. 21, 2025SRZNW STOCK PRICE INCREASE: Wt Exp 08/01/2032/Surrozen Inc on 02-21-2025 increased stock price > 10% from $0.02 to $0.03
Feb. 19, 2025SRZNW STOCK PRICE DECREASE: Wt Exp 08/01/2032/Surrozen Inc on 02-19-2025 decreased stock price > 10% from $0.03 to $0.02
Feb. 13, 2025SRZNW STOCK PRICE DECREASE: Wt Exp 08/01/2032/Surrozen Inc on 02-13-2025 decreased stock price > 10% from $0.04 to $0.03
Apr. 10, 2025AIMI STOCK PRICE DECREASE: AIM ImmunoTech Inc on 04-10-2025 decreased stock price > 10% from $0.04 to $0.03
Apr. 10, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-10-2025 decreased stock price > 10% from $0.27 to $0.20
Apr. 10, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.05
Apr. 10, 2025SLRX STOCK PRICE DECREASE: Com Par $0.0001/Salarius Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.81 to $0.60
Apr. 10, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $1.27 to $1.03
Apr. 10, 2025BGLC STOCK PRICE DECREASE: BioNexus Gene Lab Corp on 04-10-2025 decreased stock price > 10% from $2.63 to $2.17
Apr. 10, 2025BFRGW STOCK PRICE DECREASE: Wt Exp/BullFrog AI Holdings Inc on 04-10-2025 decreased stock price > 10% from $0.60 to $0.50
Apr. 10, 2025BEIGF STOCK PRICE DECREASE: BeiGene Ltd on 04-10-2025 decreased stock price > 10% from $19.01 to $15.95
Apr. 10, 2025BIAFW STOCK PRICE DECREASE: Wt Exp/Bioaffinity Technologies Inc on 04-10-2025 decreased stock price > 10% from $0.22 to $0.14
Apr. 10, 2025LEXTF STOCK PRICE DECREASE: Lexston Mining Corp on 04-10-2025 decreased stock price > 10% from $0.22 to $0.17
